GO:0043022 | ribosome binding | 1.50e-04 | 1.00e+00 | 6.739 | 2 | 3 | 27 |
GO:0016032 | viral process | 3.27e-04 | 1.00e+00 | 3.433 | 4 | 55 | 534 |
GO:0000054 | ribosomal subunit export from nucleus | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 2 | 2 |
GO:0003994 | aconitate hydratase activity | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0070062 | extracellular vesicular exosome | 2.41e-03 | 1.00e+00 | 1.850 | 6 | 104 | 2400 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0005829 | cytosol | 2.97e-03 | 1.00e+00 | 1.794 | 6 | 132 | 2496 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 3 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0042256 | mature ribosome assembly | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0006102 | isocitrate metabolic process | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 2 | 5 |
GO:0005638 | lamin filament | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0043023 | ribosomal large subunit binding | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0006413 | translational initiation | 3.51e-03 | 1.00e+00 | 4.461 | 2 | 17 | 131 |
GO:0030957 | Tat protein binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 6 |
GO:0006101 | citrate metabolic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0000082 | G1/S transition of mitotic cell cycle | 4.52e-03 | 1.00e+00 | 4.275 | 2 | 32 | 149 |
GO:0005654 | nucleoplasm | 4.58e-03 | 1.00e+00 | 2.415 | 4 | 76 | 1082 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 7 |
GO:0000028 | ribosomal small subunit assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 8 |
GO:0006098 | pentose-phosphate shunt | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 4 | 10 |
GO:0005675 | holo TFIIH complex | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 11 |
GO:0005838 | proteasome regulatory particle | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 7 | 12 |
GO:0042273 | ribosomal large subunit biogenesis | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 4 | 13 |
GO:0021591 | ventricular system development | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 13 |
GO:0010467 | gene expression | 9.33e-03 | 1.00e+00 | 2.693 | 3 | 59 | 669 |
GO:0035267 | NuA4 histone acetyltransferase complex | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 4 | 14 |
GO:0016071 | mRNA metabolic process | 9.87e-03 | 1.00e+00 | 3.693 | 2 | 31 | 223 |
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 3 | 15 |
GO:0046034 | ATP metabolic process | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 15 |
GO:0050998 | nitric-oxide synthase binding | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 |
GO:0007512 | adult heart development | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 |
GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 |
GO:0016070 | RNA metabolic process | 1.20e-02 | 1.00e+00 | 3.546 | 2 | 32 | 247 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 3 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 1 | 19 |
GO:0006281 | DNA repair | 1.33e-02 | 1.00e+00 | 3.466 | 2 | 18 | 261 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 4 | 21 |
GO:0030863 | cortical cytoskeleton | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 4 | 23 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 3 | 23 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 |
GO:0006363 | termination of RNA polymerase I transcription | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 3 | 24 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 3 | 26 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 4 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 3 | 26 |
GO:0050661 | NADP binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 4 | 27 |
GO:0006099 | tricarboxylic acid cycle | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 28 |
GO:0005730 | nucleolus | 1.99e-02 | 1.00e+00 | 1.814 | 4 | 69 | 1641 |
GO:0019005 | SCF ubiquitin ligase complex | 1.99e-02 | 1.00e+00 | 5.636 | 1 | 1 | 29 |
GO:0015992 | proton transport | 1.99e-02 | 1.00e+00 | 5.636 | 1 | 3 | 29 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 30 |
GO:0042254 | ribosome biogenesis | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 30 |
GO:0033572 | transferrin transport | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 30 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 30 |
GO:0051701 | interaction with host | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 4 | 32 |
GO:0008094 | DNA-dependent ATPase activity | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 2 | 34 |
GO:0001895 | retina homeostasis | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 34 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 35 |
GO:0034332 | adherens junction organization | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 36 |
GO:0090382 | phagosome maturation | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 5 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 4 | 37 |
GO:0005902 | microvillus | 2.60e-02 | 1.00e+00 | 5.246 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 2.60e-02 | 1.00e+00 | 5.246 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 4 | 39 |
GO:0000278 | mitotic cell cycle | 2.86e-02 | 1.00e+00 | 2.883 | 2 | 48 | 391 |
GO:0021762 | substantia nigra development | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 2 | 44 |
GO:0050434 | positive regulation of viral transcription | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 44 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 2 | 45 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 7 | 46 |
GO:0043066 | negative regulation of apoptotic process | 3.32e-02 | 1.00e+00 | 2.766 | 2 | 31 | 424 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 4 | 49 |
GO:0003743 | translation initiation factor activity | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 8 | 49 |
GO:0006091 | generation of precursor metabolites and energy | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 50 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 17 | 50 |
GO:0006879 | cellular iron ion homeostasis | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 4 | 51 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 54 |
GO:0051592 | response to calcium ion | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 3 | 55 |
GO:0012505 | endomembrane system | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 56 |
GO:0000502 | proteasome complex | 3.95e-02 | 1.00e+00 | 4.636 | 1 | 17 | 58 |
GO:0044267 | cellular protein metabolic process | 4.07e-02 | 1.00e+00 | 2.605 | 2 | 29 | 474 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 22 | 65 |
GO:0044281 | small molecule metabolic process | 4.53e-02 | 1.00e+00 | 1.837 | 3 | 58 | 1211 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.55e-02 | 1.00e+00 | 4.428 | 1 | 6 | 67 |
GO:0006289 | nucleotide-excision repair | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 1 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 20 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 6 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 22 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 2 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.35e-02 | 1.00e+00 | 4.190 | 1 | 23 | 79 |
GO:0001726 | ruffle | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 4 | 80 |
GO:0019083 | viral transcription | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 10 | 81 |
GO:0047485 | protein N-terminus binding | 5.81e-02 | 1.00e+00 | 4.068 | 1 | 5 | 86 |
GO:0006415 | translational termination | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 10 | 87 |
GO:0005634 | nucleus | 6.02e-02 | 1.00e+00 | 0.925 | 6 | 136 | 4559 |
GO:0042470 | melanosome | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 9 | 91 |
GO:0006928 | cellular component movement | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 21 | 92 |
GO:0006414 | translational elongation | 6.27e-02 | 1.00e+00 | 3.955 | 1 | 13 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 7.05e-02 | 1.00e+00 | 3.780 | 1 | 3 | 105 |
GO:0005506 | iron ion binding | 7.05e-02 | 1.00e+00 | 3.780 | 1 | 4 | 105 |
GO:0006461 | protein complex assembly | 7.44e-02 | 1.00e+00 | 3.700 | 1 | 6 | 111 |
GO:0072562 | blood microparticle | 7.44e-02 | 1.00e+00 | 3.700 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 7.50e-02 | 1.00e+00 | 3.687 | 1 | 8 | 112 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.63e-02 | 1.00e+00 | 3.661 | 1 | 11 | 114 |
GO:0019058 | viral life cycle | 7.70e-02 | 1.00e+00 | 3.649 | 1 | 13 | 115 |
GO:0000209 | protein polyubiquitination | 7.76e-02 | 1.00e+00 | 3.636 | 1 | 20 | 116 |
GO:0044237 | cellular metabolic process | 7.82e-02 | 1.00e+00 | 3.624 | 1 | 5 | 117 |
GO:0006325 | chromatin organization | 7.89e-02 | 1.00e+00 | 3.612 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 8.02e-02 | 1.00e+00 | 3.587 | 1 | 5 | 120 |
GO:0000790 | nuclear chromatin | 8.60e-02 | 1.00e+00 | 3.483 | 1 | 9 | 129 |
GO:0000086 | G2/M transition of mitotic cell cycle | 9.04e-02 | 1.00e+00 | 3.407 | 1 | 9 | 136 |
GO:0003735 | structural constituent of ribosome | 9.11e-02 | 1.00e+00 | 3.396 | 1 | 10 | 137 |
GO:0008286 | insulin receptor signaling pathway | 9.42e-02 | 1.00e+00 | 3.344 | 1 | 7 | 142 |
GO:0006457 | protein folding | 9.49e-02 | 1.00e+00 | 3.334 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 9.61e-02 | 1.00e+00 | 3.314 | 1 | 7 | 145 |
GO:0042981 | regulation of apoptotic process | 9.93e-02 | 1.00e+00 | 3.265 | 1 | 24 | 150 |
GO:0016020 | membrane | 1.01e-01 | 1.00e+00 | 1.364 | 3 | 90 | 1681 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.09e-01 | 1.00e+00 | 3.128 | 1 | 7 | 165 |
GO:0030424 | axon | 1.09e-01 | 1.00e+00 | 3.119 | 1 | 4 | 166 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.12e-01 | 1.00e+00 | 3.076 | 1 | 20 | 171 |
GO:0031625 | ubiquitin protein ligase binding | 1.17e-01 | 1.00e+00 | 3.018 | 1 | 14 | 178 |
GO:0032403 | protein complex binding | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 10 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.21e-01 | 1.00e+00 | 2.971 | 1 | 8 | 184 |
GO:0005765 | lysosomal membrane | 1.32e-01 | 1.00e+00 | 2.829 | 1 | 5 | 203 |
GO:0005759 | mitochondrial matrix | 1.47e-01 | 1.00e+00 | 2.661 | 1 | 14 | 228 |
GO:0006412 | translation | 1.49e-01 | 1.00e+00 | 2.649 | 1 | 20 | 230 |
GO:0008270 | zinc ion binding | 1.49e-01 | 1.00e+00 | 1.533 | 2 | 12 | 997 |
GO:0005975 | carbohydrate metabolic process | 1.62e-01 | 1.00e+00 | 2.511 | 1 | 9 | 253 |
GO:0004842 | ubiquitin-protein transferase activity | 1.63e-01 | 1.00e+00 | 2.500 | 1 | 6 | 255 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.69e-01 | 1.00e+00 | 2.450 | 1 | 8 | 264 |
GO:0005856 | cytoskeleton | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 12 | 291 |
GO:0006200 | ATP catabolic process | 1.85e-01 | 1.00e+00 | 2.304 | 1 | 15 | 292 |
GO:0043234 | protein complex | 1.87e-01 | 1.00e+00 | 2.290 | 1 | 18 | 295 |
GO:0016567 | protein ubiquitination | 1.87e-01 | 1.00e+00 | 2.290 | 1 | 5 | 295 |
GO:0005515 | protein binding | 1.97e-01 | 1.00e+00 | 0.523 | 6 | 184 | 6024 |
GO:0019901 | protein kinase binding | 1.99e-01 | 1.00e+00 | 2.186 | 1 | 21 | 317 |
GO:0043231 | intracellular membrane-bounded organelle | 2.00e-01 | 1.00e+00 | 2.181 | 1 | 9 | 318 |
GO:0007411 | axon guidance | 2.00e-01 | 1.00e+00 | 2.177 | 1 | 13 | 319 |
GO:0008283 | cell proliferation | 2.06e-01 | 1.00e+00 | 2.137 | 1 | 14 | 328 |
GO:0005524 | ATP binding | 2.25e-01 | 1.00e+00 | 1.152 | 2 | 60 | 1298 |
GO:0005925 | focal adhesion | 2.27e-01 | 1.00e+00 | 1.978 | 1 | 19 | 366 |
GO:0007155 | cell adhesion | 2.28e-01 | 1.00e+00 | 1.967 | 1 | 6 | 369 |
GO:0005737 | cytoplasm | 2.51e-01 | 1.00e+00 | 0.615 | 4 | 110 | 3767 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.55e-01 | 1.00e+00 | 1.783 | 1 | 10 | 419 |
GO:0055114 | oxidation-reduction process | 2.56e-01 | 1.00e+00 | 1.780 | 1 | 12 | 420 |
GO:0055085 | transmembrane transport | 2.64e-01 | 1.00e+00 | 1.729 | 1 | 10 | 435 |
GO:0007596 | blood coagulation | 2.74e-01 | 1.00e+00 | 1.664 | 1 | 18 | 455 |
GO:0006468 | protein phosphorylation | 2.77e-01 | 1.00e+00 | 1.649 | 1 | 18 | 460 |
GO:0006915 | apoptotic process | 3.25e-01 | 1.00e+00 | 1.378 | 1 | 33 | 555 |
GO:0042803 | protein homodimerization activity | 3.44e-01 | 1.00e+00 | 1.277 | 1 | 12 | 595 |
GO:0045087 | innate immune response | 3.44e-01 | 1.00e+00 | 1.275 | 1 | 24 | 596 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.30e-01 | 1.00e+00 | 0.870 | 1 | 19 | 789 |
GO:0005615 | extracellular space | 4.97e-01 | 1.00e+00 | 0.592 | 1 | 17 | 957 |
GO:0005739 | mitochondrion | 5.12e-01 | 1.00e+00 | 0.531 | 1 | 28 | 998 |
GO:0044822 | poly(A) RNA binding | 5.33e-01 | 1.00e+00 | 0.450 | 1 | 49 | 1056 |
GO:0005886 | plasma membrane | 5.58e-01 | 1.00e+00 | 0.160 | 2 | 45 | 2582 |
GO:0016021 | integral component of membrane | 7.72e-01 | 1.00e+00 | -0.459 | 1 | 27 | 1982 |